Martin Rott

Senior Associate
CV
Projects
Awards and media
E-mail
martin.rott@havelpartners.cz
Practice Areas
Industry Sectors

Martin Rott specialises in competition law, pharmaceutical law, compliance and regulation.

In competition law, Martin advises on cartels, abuse of dominance, merger clearance and foreign investment control. As part of his practice, he has represented many leading companies in proceedings before the Office for the Protection of Competition, administrative courts, and the European Commission.

In the area of pharmaceutical law, Martin focuses primarily on issues related to the distribution of medicinal products and medical devices, pricing and reimbursement regulation, and compliance. He also advises manufacturers of medicinal products and medical devices on competition issues regarding their intended projects and business strategies, including issues of dominance and abuse of dominance, setting up and changing distribution models, assessing bonus schemes and vertical agreements.  

Martin also has extensive experience in compliance advisory and has been involved in preparing and conducting competition law audits, specialised training for employees and management of major companies, and preparing compliance manuals.

Martin has been affiliated with our firm since 2017, first as a junior associate and currently as an associate.

Membership in professional associations

Czech Bar Association

Languages
Czech, English
Education
  • Charles University, Faculty of Law, Prague (2017), Mgr. (Master of Laws)
  • The University of Queensland, International Business Law (2016)
  • Universiteit Antwerpen, International and European Legal Studies Programme (2015-2016)
  • advising on representing a client in alleged IT cartel matters, including the subsequent proceedings before administrative courts
  • advising in proceedings before the European Commission in the field of telecommunications
  • advising a major pharmaceutical company on competition issues related to the entry of products into the Czech market
  • assessing a bonus system for a global medicinal product manufacturer, including the definition of the relevant market and analysis of potential exclusionary effects
  • advising a leading manufacturer of medicinal products and medical devices on a number of competition law issues, including analysis of the client’s market position, definition of the relevant market, and assessment of the intended strategy
  • advising a global medicinal product manufacturer on issues relating to dominance and changes in the distribution model
  • representing a client in proceedings before the Office for the Protection of Competition for merger clearance in the television broadcasting sector
  • representing a client in proceedings before the Office for the Protection of Competition concerning suspected abuse of dominance
  • representing companies in merger clearance proceedings before the European Commission
  • in-depth competition law audits of multinational companies, training for employees and management
HAVEL & PARTNERS, a law firm, joined the public consultation on the review of Czech merger control rules initiated by the Czech Competition Authority (the “CCA”). The proposed review may result in the most extensive changes to the current system since 2001. Experts of the competition team at HAVEL & PARTNERS submitted their comprehensive position […]
We are proud to announce our fresh contribution to the Merger Control 2024 global practice guide, a wide-ranging publication covering merger control regimes in multiple jurisdictions worldwide. Among other leading law firms, our team lead by Robert Neruda together with Lenka Štiková Gachová has prepared a section of merger control in the Czech Republic. We […]
HAVEL & PARTNERS represented a division of the leading Czech industrial group MTX Group in its participation in a major solar and wind power development and construction project in Andalusia, which is being developed by the German company Aquila Capital. The firm’s legal services encompassed a wide range of expertise, including transactional, corporate, and competition […]
As in previous years, the beginning of summer at HAVEL & PARTNERS is associated with a wave of internal promotions, which is record-breaking this year. Jiří Kunášek becomes a new equity partner with effect from 1 July, Veronika Bočanová and Ivan Houfek are promoted to the position of partner. Additional 25 attorneys are moving to […]
With the assistance from HAVEL & PARTNERS, Albatros Media recently completed its 20th acquisition, which was also the largest in its history. The publishing house acquired a 100% stake in Libristo Media, a major online bookstore specialising in foreign-language literature. Libristo Media, based in Vsetín, now has over two million customers in 25 EU countries. […]
Havel & Partners advised JSK Investments s.r.o. and its shareholders Simona and Jaromír Kijonka on the sale of a stake in Packeta s.r.o. Packeta is the parent company of a major domestic technology and logistics company, Zásilkovna, which operates not only on the Czech market but also in other EU countries. This is one of […]
The specialised M&A, banking and finance teams of HAVEL & PARTNERS provided comprehensive legal advice to Turkish company TURK Electronic Para on the acquisition of Czech fintech start-up Twisto Payments. The seller was Australian firm Zip. The financial services provider Twisto has introduced the first Buy Now, Pay Later (BNPL) payment system in the Czech […]
HAVEL & PARTNERS contributed to the Chambers and Partners Merger Control 2023 Global Practice Guide We are proud to announce our contribution to the Merger Control 2023 global practice guide, a comprehensive resource that delves into merger control regimes spanning multiple jurisdictions worldwide. Among leading law firms covering other jurisdictions, our team lead by Robert […]

BE UP TO DATE

Subscribe
Fill in your e-mail and get regular news from the world of law and business.

Contact Us

Copyright © 2024 HAVEL & PARTNERS s.r.o., advokátní kancelář
cross